Clinical trials

#Acquisition #Clinical trials #Life sciences

Beckley Psytech acquires Eleusis Therapeutics

Clinical stage company Beckley Psytech has entered into an agreement to acquire clinical-stage life science company, Eleusis Therapeutics.   Under the terms of the agreement, which has been approved by shareholders, Beckley Psytech has acquired 100% of Eleusis, receiving full developmental and commercial rights for the company’s assets… Read More

#News

Ukraine clinical research
#Clinical research #Clinical trials #Drug discovery #Russia #Ukraine

“Nothing scares us” – Ukraine’s clinical research sector begins fearless recovery

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko, Clinical Research Director at Medical Center Ok!Clinic+ to understand the impact of… Read More

#Editor's Choice #Exclusive Content

Diversity
#Clinical research #Clinical trials #Diversity #Ethnic populations #Inclusivity

New technology aims to improve diversity in clinical trials

Medidata has launched the Intelligent Trials Diversity Module to help improve the equity of clinical trials. The module will provide site-level participant demographic data including race, sex, age, and ethnicity.  The new Intelligent Trials Diversity Module will help sponsors identify sites that are more successful at enrolling diverse patients. Read More

#News

#Clinical trials #Decentralised clinical trials #Digitalisation

Cambridge Cognition set to become key player in virtual clinical trials 

Cambridge Cognition has entered into an agreement to acquire eClinicalHealth Ltd (eCH), a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.   Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly… Read More

#News

#Biomarkers #Clinical trials #Contract Research Organisations (CROs)

Digital biomarkers in pharma: Q&A with Medidata’s Mark Matson 

DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease.  How do we define digital biomarkers?  Digital biomarkers are data, or metrics, collected using digital… Read More

#Exclusive Content

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Decentralised clinical trials #Patient centricity

Covid-related changes to clinical trials here to stay

The Covid-19 pandemic has led to improvements in clinical trial processes and a more technology-driven approach, a new report from Medidata has revealed. The report ‘European Industry Research Report: The Future of Clinical Trials’ includes insights from 400 clinical trial executives across the United Kingdom, France, Germany and Switzerland. The… Read More

#Covid-19 #News

#Clinical trials #Drug development #Opinion #Patient centricity #Public health

What can patients do to give input into clinical trial design? 

Business and profitability remain unquestionably important in the drug discovery community. However, the industry’s overarching goal of public health and the betterment of society have never been more apparent than in the aftermath of the pandemic and when observing the heights scientists reached through determination and collaboration in the fight… Read More

#Exclusive Content #Opinion

A clinical trial
#APAC #Clinical research #Clinical trial design #Clinical trials #Drug development

Cytel hopes to accelerate drug development in APAC region

Cytel has expanded its operations into the Asia-Pacific region (APAC), with hopes of optimising clinical trial design in the area. Cytel works with its clients on various aspects of clinical trials, including statistical design, implementation and regulatory acceptance, with the aim of helping them reduce costs, shorten timelines, and better… Read More

#News

SARS-CoV-2 virus particles
#Antibodies #Biomarkers #Clinical trials #Coronavirus #Covid-19 #Drug development #SARS-CoV-2

SARS-CoV-2 antigen levels could predict patient outcomes

The amount of SARS-CoV-2 antibodies in the blood of patients hospitalised with Covid-19 could be used to predict illness severity and other clinical outcomes.  A new study, published in the Annals of Internal Medicine, shows that higher levels of viral antigen in the blood, which… Read More

#Covid-19 #News

#Clinical trials #Covid-19 #Monkeypox

Covid researchers launch Monkeypox study  

A new study investigating a potential treatment for people who have been diagnosed with monkeypox has been launched by the same team who helped develop Covid-19 treatments.   Led by the University of Oxford, the PLATINUM study will investigate the use of Tecovirimat to see if it can… Read More

#News

EMA concept
#Clinical trials #EMA #Oncology #Regulatory

Combination treatment for AML closer to approval following EMA nod

The European Medicines Agency (EMA) has granted a Marketing Authorisation Application (MAA) for a combination treatment targeting adults with acute myeloid leukaemia (AML) who are not candidates for standard induction chemotherapy.  The MMA was granted to Otsuka Pharmaceutical and Astex Pharmaceuticals’ oral fixed-dose combination of decitabine and cedazuridine (ASTX727).   The… Read More

#Cancer Research #News #Regulatory

#Biologics / Biotechnology #Business #Clinical trials #Investment

Ryvu Therapeutics receives €22m to advance cancer portfolio  

Clinical-stage drug discovery company Ryvu Therapeutics has received €22 million from the European Investment Bank (EIB) to help it advance its portfolio of cancer treatments.   The funding, which is being provided under the EIB’s venture debt instrument, will help Ryvu finance its development pipeline of new cancer treatments from discovery… Read More

#Business & Investment #News

#Biology #Clinical trials #Diversity #Oncology

What it takes to make cancer research more inclusive

The drug discovery sector is working to address cancer disparities. Anita Ramanathan examines the importance of inclusivity and diversity throughout the drug discovery and development process.  While the risk of cancer is universal, some groups are disproportionately affected by cancer compared to others. Disparities resulting from genetic, environmental, social, and… Read More

#Cancer Research #Exclusive Content

#Clinical trials #Immunology / Virology & Vaccines #Malaria #US

Positive results for US Malaria vaccine, trial shows 

A monoclonal antibody (mAb) treatment for the prevention of Malaria has shown encouraging results in a US Phase I clinical trial.   The mAb, known as L9LS, was developed by scientists at the National Institutes of Health’s (NIH) Vaccine Research Centre (VRC). L9LS is a laboratory-made version of… Read More

#News

#Clinical trials #Neurology

Oxeia Biopharmaceuticals encouraged by concussion treatment 

Clinical stage biotech company Oxeia Biopharmaceuticals has announced interim results from a Phase II trial investigating its treatment for concussion.  Oxeia’s OXE103 treatment is targeting concussion in a bid to address underlying neuro-metabolic dysfunction and axonal injury. The company has now completed an interim analysis of its… Read More

#News